drugset / Trial / NCT01279213

Clozapine/Paliperidone Versus Clozapine/Placebo in Resistant Schizophrenia

NCT01279213

Phase 4 Completed 70 enrolled Universidad Nacional de Rosario
RandomizedParallel-groupQuadruple-blindTreatment

Summary

augmentation of clozapine with paliperidone in the treatment of resistant schizophrenia has not been tested until now in randomized controlled trials. This combination is supposed to have therapeutic efficacy in the treatment of resistant schizophrenia.

Timeline

Start
2009-01
Primary completion
2009-10
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Paliperidone Unknown 3 mg Oral
Comparator Paliperidone Unknown 6 mg Oral
Comparator Paliperidone Unknown 9 mg Oral
Comparator Paliperidone Unknown 12 mg Oral
Comparator Clozapine Other / unclassified

Indications